CRISPR Therapeutics Appoints Samarth Kulkarni, Ph.D. as President, Expanding Role Beyond Chief Business Officer … – GlobeNewswire (press release)
NormanObserver.com |
CRISPR Therapeutics Appoints Samarth Kulkarni, Ph.D. as President, Expanding Role Beyond Chief Business Officer …
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass., May 04, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on developing transformative gene-based therapeutics for patients with serious diseases, … MPEG LA invites CRISPR-Cas9 patents to be pooled in a one-stop license Crispr Therapeutics AG (CRSP) Insider Sells $363102.42 in Stock Insider Selling: Crispr Therapeutics AG (CRSP) Insider Sells $91861.56 in Stock |
